{"id":250764,"date":"2026-09-17T09:23:05","date_gmt":"2026-09-17T03:53:05","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=250764"},"modified":"2026-09-17T09:23:05","modified_gmt":"2026-09-17T03:53:05","slug":"why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/","title":{"rendered":"Dr. Lal Pathlabs Share Price Hits Fresh 52-Week High at Rs 1,911: Key Reasons Behind the Rally"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr. Lal Pathlabs Ltd. (LALPATHLAB)<\/a> share price reached a fresh 52-week high of Rs 1,910.5 today and later stood at Rs 1,897, up 0.16% from the previous close. Market cap was Rs 31,975.2 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 17 September 2026 at 9:18 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Dr. Lal Pathlabs Share Price moved to Rs 1,897 on 17 September 2026, up Rs 3 or 0.16% from the previous close, after touching a fresh 52-week high of Rs 1,910.50 during the session. The company\u2019s market capitalisation stands at Rs 31,975.2 crore. This Dr. Lal Pathlabs Share Price update is relevant because the stock reached a new yearly high even as the day\u2019s gain remained modest, which keeps the move fact-based rather than exaggerated. The supplied data confirms the price event, while it does not establish a company-specific catalyst. For readers tracking Dr. Lal Pathlabs Stock News, the key takeaway is that price action, valuation and sector context all matter in this fresh 52-week high setup. Univest is covering the event with a focus on verified numbers and market structure.<\/p>\n<p>The latest Dr. Lal Pathlabs Share Price Today movement also places the stock close to its session high, with an opening price of Rs 1,896.65 and a low of Rs 1,888. The stock has therefore traded in a relatively tight range around the new one-year high. In a market where 52 Week High Stocks often enter shortlists for stock analysis, this move puts Dr. Lal Pathlabs Share Price News on investor screens without implying any cause beyond the supplied data. Univest looks at the move through price, valuation and healthcare-sector comparisons rather than assumptions.<\/p>\n<p>For those following Dr. Lal Pathlabs Share Price Live, the important context is that the stock now sits above its 200-day average of Rs 1,635.32, while it remains below the 50-day average of Rs 1,912.42. That combination helps frame the move within a broader share price update, but the session data itself should still be read as a fresh 52-week high event first and foremost. Univest therefore treats this as a verified market milestone, not a forecast.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#Dr_Lal_Pathlabs_Share_Price_Today_Price_Action_Analysis\" title=\"Dr. Lal Pathlabs Share Price Today: Price Action Analysis\">Dr. Lal Pathlabs Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#Dr_Lal_Pathlabs_Ltd_LALPATHLAB_Fundamental_Analysis\" title=\"Dr. Lal Pathlabs Ltd. (LALPATHLAB) Fundamental Analysis\">Dr. Lal Pathlabs Ltd. (LALPATHLAB) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#Why_Investors_Are_Watching_Dr_Lal_Pathlabs\" title=\"Why Investors Are Watching Dr. Lal Pathlabs\">Why Investors Are Watching Dr. Lal Pathlabs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#About_Dr_Lal_Pathlabs\" title=\"About Dr. Lal Pathlabs\">About Dr. Lal Pathlabs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#Track_Dr_Lal_Pathlabs_Share_Price_on_Univest\" title=\"Track Dr. Lal Pathlabs Share Price on Univest\">Track Dr. Lal Pathlabs Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#Why_did_Dr_Lal_Pathlabs_Share_Price_hit_a_fresh_52-week_high\" title=\"Why did Dr. Lal Pathlabs Share Price hit a fresh 52-week high?\">Why did Dr. Lal Pathlabs Share Price hit a fresh 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#What_is_Dr_Lal_Pathlabs_Share_Price_today\" title=\"What is Dr. Lal Pathlabs Share Price today?\">What is Dr. Lal Pathlabs Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#What_is_the_market_capitalisation_of_Dr_Lal_Pathlabs\" title=\"What is the market capitalisation of Dr. Lal Pathlabs?\">What is the market capitalisation of Dr. Lal Pathlabs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#How_does_Dr_Lal_Pathlabs_compare_on_valuation\" title=\"How does Dr. Lal Pathlabs compare on valuation?\">How does Dr. Lal Pathlabs compare on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#What_do_Dr_Lal_Pathlabs_ROE_and_ROCE_show\" title=\"What do Dr. Lal Pathlabs ROE and ROCE show?\">What do Dr. Lal Pathlabs ROE and ROCE show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#What_is_Dr_Lal_Pathlabs_EPS_and_book_value\" title=\"What is Dr. Lal Pathlabs EPS and book value?\">What is Dr. Lal Pathlabs EPS and book value?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#What_is_Dr_Lal_Pathlabs_dividend_yield\" title=\"What is Dr. Lal Pathlabs dividend yield?\">What is Dr. Lal Pathlabs dividend yield?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-dr-lal-pathlabs-ltd-share-price-52-week-high-2026-09-17\/#How_does_Dr_Lal_Pathlabs_compare_with_peers\" title=\"How does Dr. Lal Pathlabs compare with peers?\">How does Dr. Lal Pathlabs compare with peers?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_Pathlabs_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Dr. Lal Pathlabs Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,897<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,894<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 3 (+0.16%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,896.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,910.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,888<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.07 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 31,975.2 crore<\/td>\n<\/tr>\n<\/table>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) traded at Rs 1,897 versus the previous close of Rs 1,894, a rise of 0.16%. The stock opened at Rs 1,896.65, reached a high of Rs 1,910.5 and touched a low of Rs 1,888.<\/p>\n<p>The Dr. Lal Pathlabs Share Price Today action shows a rise from Rs 1,894 to Rs 1,897, with the stock touching an intraday high of Rs 1,910.50 and an intraday low of Rs 1,888. The opening price of Rs 1,896.65 was close to the previous close, which makes the day\u2019s movement look measured rather than sharp. Turnover stood at Rs 0.07 crore, reflecting the value transacted in the session data supplied here. For readers scanning Dr. Lal Pathlabs Share Price News Today, the verified fact is simple: the stock marked a fresh 52-week high and held near that level through the session.<\/p>\n<p>This kind of Dr. Lal Pathlabs Share Price Update matters because it combines a yearly high with a narrow trading band on the day. The distance between the session low and high was Rs 22.50, and the stock finished just below the peak at Rs 1,897. In stock market today searches, that pattern is often enough to place a counter among stocks in news and market movers, but the article should remain anchored to what is supplied. Univest is highlighting the event because the 52-week high itself is the factual headline, while the day\u2019s move shows how close the close was to the session peak.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_Pathlabs_Ltd_LALPATHLAB_Fundamental_Analysis\"><\/span><strong>Dr. Lal Pathlabs Ltd. (LALPATHLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 31,975.2 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">58.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.37%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">29.56%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32.29<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 155.67<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.08%<\/td>\n<\/tr>\n<\/table>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) fundamental metrics show P\/E 58.67x, P\/B 12.17x, ROE 22.37%, ROCE 29.56%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Dr. Lal Pathlabs Ltd. has a market capitalisation of Rs 31975.2 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 58.67x, P\/B at 12.17x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.37% and ROCE of 29.56%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 32.29, book value per share of Rs 155.67, dividend yield of 1.08%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 46.22x, median ROE of 13.07%, median ROCE of 15.86%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Hospital &amp; Healthcare Services<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">58.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">46.22x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">100.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.36x to 1,593x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.75x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.37%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.07%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">29.56%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.86%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 31,975.2 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 476.58 crore<\/td>\n<\/tr>\n<\/table>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) is classified under sector: Healthcare and industry: Hospital &amp; Healthcare Services.<\/p>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P\/E ratio of 58.67x, which is above the benchmark median of 46.22x, a difference of +26.94%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROE of 22.37%, which is above the benchmark median of 13.07%, a difference of +71.16%. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a ROCE of 29.56%, which is above the benchmark median of 15.86%, a difference of +86.38%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kims\/krishna-institute-of-medical-sciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Krishna Institute of Medical Sciences Ltd<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KIMS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32,204<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">157.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.52<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/medanta\/global-health-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Global Health Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MEDANTA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38,068.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">67.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.38<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/nh\/narayana-hrudayalaya-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Narayana Hrudayalaya Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">NH<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38,754.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.86<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/agarwaleye\/dr-agarwals-health-care-l-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>DR AGARWALS HEALTH CARE L<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AGARWALEYE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15,935.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">107.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.14<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/asterdm\/aster-dm-healthcare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Aster DM Healthcare Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ASTERDM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">64,704.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">202.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.22<\/td>\n<\/tr>\n<\/table>\n<p>Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a P\/E ratio of 58.67x compared with the displayed peer median of 107.88x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 22.37% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 29.56% versus the displayed peer median of 16.2%, providing a capital-efficiency comparison. Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a market capitalisation of Rs 31,975.2 crore. Among the 5 peers shown, 4 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Dr_Lal_Pathlabs\"><\/span><strong>Why Investors Are Watching Dr. Lal Pathlabs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Dr. Lal Pathlabs Share Price touched a fresh 52-week high of Rs 1,910.50 and last traded at Rs 1,897.<\/li>\n<li>The day change was Rs 3, or 0.16%, against the previous close of Rs 1,894.<\/li>\n<li>Market capitalisation stands at Rs 31,975.2 crore, placing the company above the industry median market cap.<\/li>\n<li>P\/E is 58.67, P\/B is 12.17, ROE is 22.37% and ROCE is 29.56%.<\/li>\n<li>Revenue and net profit both moved higher in the latest annual periods supplied.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Dr_Lal_Pathlabs\"><\/span><strong>About Dr. Lal Pathlabs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr. Lal Pathlabs Ltd. operates in the Healthcare sector and the Hospital &amp; Healthcare Services industry. The supplied data identifies it as a listed company on NSE and BSE under the symbol LALPATHLAB. Its recent financial indicators include revenue, net profit, EPS, book value and dividend yield, which together provide a factual company profile for readers tracking Dr. Lal Pathlabs Company News and Dr. Lal Pathlabs Latest News.<\/p>\n<p>For investors following Dr. Lal Pathlabs Share Price and Dr. Lal Pathlabs Share Price Today, the company\u2019s profile is best understood through the numbers provided here: market capitalisation, profitability, valuation and sector comparison. Univest presents the facts as a share price update rather than a narrative built on assumptions. That approach helps keep Dr. Lal Pathlabs Stock News grounded in verified data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Dr_Lal_Pathlabs_Share_Price_on_Univest\"><\/span><strong>Track Dr. Lal Pathlabs Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr. Lal Pathlabs Ltd. (LALPATHLAB) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Readers can track Dr. Lal Pathlabs Share Price on Univest for live price updates, fundamental ratios, shareholding pattern, 52-week levels, sector context and stock analysis. Univest also brings together Dr. Lal Pathlabs Share Price Today, Dr. Lal Pathlabs Share News and the latest company metrics in one place for easier review.<\/p>\n<p>For users comparing Dr. Lal Pathlabs Stock News with broader healthcare-sector movements, Univest provides a structured view of valuation, return ratios and peer data. That makes it easier to follow Dr. Lal Pathlabs Share Price Live without relying on scattered market snippets. Univest keeps the coverage factual, current and event-led.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Dr_Lal_Pathlabs_Share_Price_hit_a_fresh_52-week_high\"><\/span><strong>Why did Dr. Lal Pathlabs Share Price hit a fresh 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that Dr. Lal Pathlabs Share Price touched Rs 1,910.50, a fresh 52-week high. It does not establish a company-specific catalyst, so the event should be read as verified price action only.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Dr_Lal_Pathlabs_Share_Price_today\"><\/span><strong>What is Dr. Lal Pathlabs Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Lal Pathlabs Share Price last traded at Rs 1,897, up Rs 3 or 0.16% from the previous close of Rs 1,894. The stock also touched Rs 1,910.50 during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Dr_Lal_Pathlabs\"><\/span><strong>What is the market capitalisation of Dr. Lal Pathlabs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Lal Pathlabs has a market capitalisation of Rs 31,975.2 crore. That places the company well above the same-industry benchmark median market cap of Rs 476.58 crore in the supplied healthcare dataset.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Dr_Lal_Pathlabs_compare_on_valuation\"><\/span><strong>How does Dr. Lal Pathlabs compare on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Lal Pathlabs trades at a P\/E of 58.67 and a P\/B of 12.17. Both sit above the sector medians of 46.22 and 3.75, respectively, within the supplied Hospital &amp; Healthcare Services benchmark.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Dr_Lal_Pathlabs_ROE_and_ROCE_show\"><\/span><strong>What do Dr. Lal Pathlabs ROE and ROCE show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ROE is 22.37% and ROCE is 29.56%. Both are above the benchmark medians of 13.07% and 15.86%, which gives the stock a stronger return profile than many peers in the supplied set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Dr_Lal_Pathlabs_EPS_and_book_value\"><\/span><strong>What is Dr. Lal Pathlabs EPS and book value?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> EPS is 32.29 and book value is Rs 155.67. EPS reflects earnings per share, while book value shows the accounting net worth behind each share. Both help frame the share price in financial terms.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Dr_Lal_Pathlabs_dividend_yield\"><\/span><strong>What is Dr. Lal Pathlabs dividend yield?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied dividend yield is 1.08%. It is a current yield metric and should be read together with price, valuation and financial results rather than as a guaranteed future payout.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Dr_Lal_Pathlabs_compare_with_peers\"><\/span><strong>How does Dr. Lal Pathlabs compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr. Lal Pathlabs\u2019 P\/E is lower than several peers such as KIMS, MEDANTA and Aster DM Healthcare, while its ROE and ROCE are stronger than many names in the supplied peer set. That is the main comparison takeaway.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Lal Pathlabs Ltd. Share Price hits a new 52-week high at Rs 1,897. marking a 0.16% rise today. Market cap stands at Rs 31,975.2 crore.<\/p>\n","protected":false},"author":29,"featured_media":250763,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-250764","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["250763"],"rank_math_title":["Dr. Lal Pathlabs Share Price: 52-week high and valuation"],"rank_math_description":["Dr. Lal Pathlabs Share Price hits a fresh 52-week high at Rs 1,897. See today\u2019s move, valuation, fundamentals, peers and sector context."],"rank_math_focus_keyword":["Dr. Lal Pathlabs Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Dr_Lal_Pathlabs_Share_Price_Hits_Fresh_52_Week_High_at_Rs_1911_Key_Reasons_Behind_the_Rally_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/250764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=250764"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/250764\/revisions"}],"predecessor-version":[{"id":250765,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/250764\/revisions\/250765"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/250763"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=250764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=250764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=250764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}